The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell ActivationJean-Pierre Evenou, Gottfried Baier, Thomas Gruber et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 160
Discovery of 3-(1<i>H</i>-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C IsotypesJürgen Wagner, Sylvain Cottens, Peter Matt et al.|Journal of Medicinal Chemistry|2009Cited by 135
Sanglifehrin−Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray Crystal Structure, and Binding DataRichard Sedrani, Jürgen Wagner, Jörg Kallen et al.|Journal of the American Chemical Society|2003Cited by 113
Macrolide Analogues of the Novel Immunosuppressant Sanglifehrin: New Application of the Ring-Closing Metathesis ReactionL. M. MARTIN CABREJAS, Jürgen Wagner, Stefan Rohrbach et al.|Angewandte Chemie International Edition|1999Cited by 47
Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of PsoriasisJürgen Wagner, Sylvain Cottens, Bernard Faller et al.|Journal of Medicinal Chemistry|2011Cited by 39